Benzinga | Feb 5, 2021 09:26AM EST

HC Wainwright & Co. Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $207

HC Wainwright & Co. analyst Oren Livnat maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $195 to $207.